FIELD: chemistry.
SUBSTANCE: invention relates to a pharmaceutical composition for treating or preventing epilepsy, pain, depression, anxiety, pshychosis, fainting, hypokinesia, intracranial disorders, neurodegenerative diseases, panic, inflammatory diseases, insomnia, gastroenteric disorders, afflux, restless legs syndrome, uroclepsia or alcohol withdrawal syndrome in patients in need of such treatment, involving a therapeutically efficient amount of crystalline 1-{[(α-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, and a pharmaceutically acceptable carrier, in which crystalline 1-{[(α-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid has absorption characteristic peaks at 7.0°±0.3°, 8.2°±0.3°, 10.5°±0.3°, 12.8°±0.3°, 14.9°±0.3° and 16.4°+0.3° on an X-ray powder diffraction pattern using Cu Kα radiation.
EFFECT: good physical and chemical properties for pharmaceutical production processes.
38 cl, 2 dwg, 5 ex
| Title |
Year |
Author |
Number |
| TREATMENT OR PREVENTION OF RESTLESS LEGS SYNDROME WITH USING PROMEDICINES OF GABA ANALOGUES |
2004 |
- Barret Ronal'D V.
- Kenafaks Daniel' M.
|
RU2377234C2 |
| TREATMENT AND PREVENTION OF RESTLESS LEG SYNDROME WITH USING GABA ANALOGUE PRODRUGS |
2004 |
- Barret Ronal'D V.
- Kenafaks Daniel' M.
|
RU2458049C2 |
| DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN |
2005 |
- Kandi Kennet K.
- Sastri Srikonda
- Leung Mansh'Ju
- Kadri Baladzhi V.
- Stehch Pol Eh.
|
RU2440112C2 |
| CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]BENZOIC ACID, AND USE THEREOF AND METHODS FOR PREPARING |
2007 |
- Al'Msted Nil G.
- Khvang Piter Seongvoo
- Moon Joung-Choon
|
RU2474577C2 |
| CRYSTALLINE FORMS OF {[1-CYANO-5-(4-CHLOROPHENOXY)-4-HYDROXY-ISOQUINOLINE-3-CARBONYL]-AMINO}-ACETIC ACID |
2014 |
- Vitshi Klaudiya
- Tompson Majkl D.
- Park Yun Min
- Arend Majkl P.
|
RU2666144C2 |
| TARTRATE SALTS OF 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8-AZABICYCLO[3,2,1]OCTANE |
2004 |
- Frestrup Brajan
- Vot'En Frank
- Ensen Klaus Snej
|
RU2348631C2 |
| CRYSTALLINE FORM AND TOSYLATE OF TETRACYCLINE COMPOUND, CRYSTALLINE FORM OF SAID TOSYLATE AND POLYMORPH THEREOF, METHOD OF PRODUCING TOSYLATE OF TETRACYCLINE COMPOUND, POLYMORPH OBTAINED USING SAID METHOD, AND PHARMACEUTICAL COMPOSITIONS BASED ON SAID CRYSTALLINE FORM AND POLYMORPH |
2009 |
- Uorchol Tadeush
- Tsvetovich Rajmond
|
RU2500665C2 |
| 2-CHLORO-4-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-IMIDAZOL-4-YLETHINYL]-PYRIDINE MONOSULPHATE SALT AND CRYSTALLINE FORM THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAID SALT AND PRODUCTION METHOD THEREOF |
2007 |
- Kliri Tomas P.
- Glomme Aleksandr
- Grassmann Olaf
- Kvan Sjan'-Min
- Mejer Roland
- Miller Dorin
- Mog Regina
- Rorer Frantsiska E.
- Jang Dzhejson
|
RU2460728C2 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION |
2007 |
- Kopelevich Vjacheslav Mikhajlovich
- Pozdnev Vladimir Fedorovich
|
RU2359962C1 |
| CRYSTALLINE IRINOTECAN HYDROCHLORIDE POLYMORPHOUS FORM, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2003 |
- Forino Romual'Do
- Barbudzhan Natale
- Dzamp'Eri Massimo
- Tomazi Attilio
|
RU2300535C2 |
